04/01/2026
Metabolic dysfunction-associated steatohepatitis (Metabolic dysfunction-associated steatohepatitis (MASH)) is rapidly becoming one of the most important challenges in hepatology and metabolic care. Early monitoring and accurate assessment of treatment response are critical to improving patient outcomes.
๐ Free On-Demand CME for Clinicians
Monitoring Treatment Success in MASH provides practical insights into:
โข Monitoring treatment response in patients with MASH
โข Using non-invasive tools and biomarkers in clinical practice
โข Applying evidence-based strategies for patient management
Learn from leading faculty:
๐จโโ๏ธ Naim Alkhouri, MD
๐ฉโโ๏ธ Sonal Kumar, MD, MPH
๐จโโ๏ธ Brian Lam, MSHS, PA-C
โ FREE On-Demand Activity
โ 1 AMA PRA Category 1 Creditโข | 1 Contact Hour
๐ Access the activity:
https://ow.ly/YT7m50Yr9gW